Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 01 04:00PM ET
576.33
Dollar change
+6.15
Percentage change
1.08
%
IndexS&P 500 P/E37.30 EPS (ttm)15.45 Insider Own0.17% Shs Outstand386.65M Perf Week2.06%
Market Cap219.76B Forward P/E23.75 EPS next Y24.27 Insider Trans-11.21% Shs Float380.67M Perf Month6.93%
Income6.00B PEG5.54 EPS next Q4.73 Inst Own91.96% Short Float0.76% Perf Quarter16.92%
Sales42.86B P/S5.13 EPS this Y0.07% Inst Trans0.05% Short Ratio1.71 Perf Half Y3.10%
Book/sh120.87 P/B4.77 EPS next Y12.53% ROA6.12% Short Interest2.91M Perf Year7.02%
Cash/sh21.20 P/C27.19 EPS next 5Y6.74% ROE13.22% 52W Range415.60 - 593.17 Perf YTD8.58%
Dividend Est.1.52 (0.26%) P/FCF31.73 EPS past 5Y16.37% ROI7.56% 52W High-2.84% Beta0.80
Dividend TTM1.40 (0.24%) Quick Ratio1.39 Sales past 5Y12.53% Gross Margin39.06% 52W Low38.67% ATR (14)9.95
Dividend Ex-DateDec 14, 2023 Current Ratio1.75 EPS Y/Y TTM-12.51% Oper. Margin17.39% RSI (14)67.37 Volatility1.52% 1.73%
Employees122000 Debt/Eq0.78 Sales Y/Y TTM-4.58% Profit Margin13.99% Recom1.65 Target Price598.25
Option/ShortYes / Yes LT Debt/Eq0.70 EPS Q/Q4.76% Payout9.06% Rel Volume0.85 Prev Close570.18
Sales Surprise1.43% EPS Surprise0.46% Sales Q/Q-4.93% EarningsJan 31 BMO Avg Volume1.70M Price576.33
SMA203.86% SMA505.65% SMA20011.05% Trades Volume1,440,168 Change1.08%
Date Action Analyst Rating Change Price Target Change
Jan-24-24Downgrade Barclays Overweight → Equal Weight $475 → $555
Jan-08-24Downgrade Bernstein Outperform → Mkt Perform
Dec-18-23Initiated HSBC Securities Buy $610
Dec-13-23Initiated Wolfe Research Outperform $575
Oct-26-23Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Oct-25-23Upgrade Wells Fargo Underweight → Equal Weight $52 → $475
Sep-28-23Initiated Bernstein Outperform $603
Sep-06-23Resumed Citigroup Buy $625
Jul-19-23Reiterated Robert W. Baird Outperform $670 → $664
Jul-19-23Initiated Raymond James Outperform $595
Today 11:30AM
09:00AM
08:00AM
Feb-29-24 09:30PM
06:00PM
03:04PM Loading…
03:04PM
Feb-28-24 08:00AM
Feb-26-24 01:19PM
Feb-23-24 12:02AM
Feb-21-24 05:00PM
Feb-20-24 06:00AM
Feb-19-24 10:55AM
Feb-17-24 01:29PM
Feb-15-24 04:13PM
06:11AM
10:01AM Loading…
Feb-14-24 10:01AM
Feb-13-24 02:41PM
Feb-10-24 10:25AM
Feb-06-24 08:43AM
08:12AM
06:01AM
Feb-02-24 11:02AM
06:19AM
Jan-31-24 10:31PM
04:43PM
03:04PM
12:15PM
12:14PM
12:07PM
11:23AM
10:38AM Loading…
10:38AM
09:30AM
09:13AM
07:17AM
07:10AM
06:37AM
06:27AM
06:17AM
06:11AM
06:05AM
06:00AM
Jan-30-24 07:08PM
09:15AM
06:01AM
02:30AM
Jan-29-24 12:56PM
Jan-26-24 09:15AM
Jan-24-24 03:08PM
Jan-22-24 06:00PM
Jan-18-24 06:15PM
Jan-17-24 07:57AM
Jan-16-24 11:57AM
06:00AM
Jan-12-24 06:00PM
Jan-11-24 06:15PM
Jan-10-24 12:01PM
11:58AM
Jan-05-24 06:00PM
05:19AM
05:19AM
02:37AM
Jan-04-24 06:15PM
04:01PM
08:00AM
12:32AM
Jan-03-24 04:12PM
12:01PM
10:09AM
08:00AM
Jan-02-24 08:00AM
Dec-30-23 09:30AM
09:27AM
Dec-27-23 06:15PM
Dec-26-23 10:51AM
07:08AM
Dec-22-23 08:56AM
Dec-20-23 06:00PM
Dec-19-23 08:00AM
06:00AM
Dec-18-23 08:45AM
Dec-15-23 08:00AM
Dec-14-23 06:00PM
Dec-12-23 08:52AM
Dec-11-23 09:57AM
Dec-07-23 09:54AM
09:16AM
Dec-06-23 03:00AM
Dec-05-23 06:03AM
Dec-04-23 06:15AM
Dec-01-23 08:00AM
Nov-30-23 02:30PM
11:51AM
Nov-29-23 05:32PM
Nov-28-23 08:13PM
08:00AM
Nov-26-23 05:56AM
Nov-24-23 11:31AM
03:19AM
Nov-21-23 06:02AM
Nov-20-23 06:52AM
Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment is composed of a portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs and vaccines, as well as diagnosis of infection and disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment provides diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment is involved in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CASPER MARC NChairman & CEOFeb 28Option Exercise190.5910,0001,905,900138,485Feb 29 04:56 PM
CASPER MARC NChairman & CEOFeb 28Sale570.1810,0005,701,759128,485Feb 29 04:56 PM
CASPER MARC NChairman & CEOFeb 27Option Exercise190.5910,0001,905,900138,485Feb 29 04:56 PM
CASPER MARC NChairman & CEOFeb 27Sale564.7210,0005,647,196128,485Feb 29 04:56 PM
CASPER MARC NChairman & CEOFeb 15Sale550.625,5473,054,29043,608Feb 20 04:51 PM
Spar Debora LDirectorFeb 12Sale546.9716489,7031,207Feb 14 04:36 PM
Boxer Michael ASVP and General CounselFeb 07Option Exercise192.9814,5662,810,94727,467Feb 08 04:53 PM
Boxer Michael ASVP and General CounselFeb 07Sale562.0014,5668,186,09212,901Feb 08 04:53 PM
CASPER MARC NChairman & CEOFeb 07Sale555.6310,0005,556,28749,155Feb 08 04:51 PM
CASPER MARC NChairman & CEONov 07Option Exercise157.681,600252,288132,775Nov 08 04:09 PM
CASPER MARC NChairman & CEONov 07Sale460.251,600736,404131,175Nov 08 04:09 PM
CASPER MARC NChairman & CEONov 06Option Exercise157.6810,0001,576,800141,175Nov 08 04:09 PM
CASPER MARC NChairman & CEONov 06Sale454.4110,0004,544,053131,175Nov 08 04:09 PM
CASPER MARC NChairman & CEONov 03Option Exercise157.6810,0001,576,800141,175Nov 06 04:34 PM
CASPER MARC NChairman & CEONov 03Sale456.1510,0004,561,459131,175Nov 06 04:34 PM
CASPER MARC NChairman & CEONov 02Option Exercise157.6810,0001,576,800141,175Nov 06 04:34 PM
CASPER MARC NChairman & CEONov 02Sale445.4910,0004,454,880131,175Nov 06 04:34 PM
Pettiti GianlucaExecutive Vice PresidentAug 30Option Exercise253.993,000761,97020,556Aug 31 04:15 PM
Pettiti GianlucaExecutive Vice PresidentAug 30Sale557.773,0001,673,31017,556Aug 31 04:15 PM
CASPER MARC NChairman & CEOAug 08Option Exercise157.681,600252,288136,930Aug 09 04:01 PM
CASPER MARC NChairman & CEOAug 08Sale550.601,600880,960135,330Aug 09 04:01 PM
CASPER MARC NChairman & CEOAug 07Option Exercise157.6810,0001,576,800145,330Aug 09 04:01 PM
CASPER MARC NChairman & CEOAug 07Sale551.9410,0005,519,370135,330Aug 09 04:01 PM
CASPER MARC NChairman & CEOAug 04Option Exercise157.6810,0001,576,800145,330Aug 07 04:05 PM
CASPER MARC NChairman & CEOAug 04Sale550.3310,0005,503,317135,330Aug 07 04:05 PM
CASPER MARC NChairman & CEOAug 03Option Exercise157.6810,0001,576,800151,330Aug 07 04:05 PM
CASPER MARC NChairman & CEOAug 03Sale549.0010,0005,490,050141,330Aug 07 04:05 PM
Williamson StephenSr. VP and CFOAug 01Option Exercise190.5914,1002,687,31941,493Aug 02 04:33 PM
Williamson StephenSr. VP and CFOAug 01Sale550.0014,1007,755,00027,393Aug 02 04:33 PM
Williamson StephenSr. VP and CFOJul 31Option Exercise190.5915,0002,858,85042,393Aug 02 04:33 PM
Williamson StephenSr. VP and CFOJul 31Sale557.4215,0008,361,30027,393Aug 02 04:33 PM
Boxer Michael ASVP and General CounselJun 26Buy526.1542,10513,101Oct 06 04:23 PM
CASPER MARC NChairman & CEOMay 09Option Exercise157.681,600252,288142,930May 10 04:13 PM
CASPER MARC NChairman & CEOMay 09Sale534.821,600855,710141,330May 10 04:13 PM
CASPER MARC NChairman & CEOMay 08Option Exercise157.6810,0001,576,800151,330May 10 04:13 PM
CASPER MARC NChairman & CEOMay 08Sale544.4010,0005,444,003141,330May 10 04:13 PM
CASPER MARC NChairman & CEOMay 05Option Exercise157.6810,0001,576,800151,330May 08 04:21 PM
CASPER MARC NChairman & CEOMay 05Sale545.2210,0005,452,236141,330May 08 04:21 PM
CASPER MARC NChairman & CEOMay 04Option Exercise157.6810,0001,576,800151,330May 08 04:21 PM
CASPER MARC NChairman & CEOMay 04Sale546.9810,0005,469,779141,330May 08 04:21 PM
CASPER MARC NChairman & CEOMar 14Sale553.797,5004,153,45259,155Mar 15 04:07 PM
CASPER MARC NChairman & CEOMar 13Sale544.497,5004,083,69366,655Mar 15 04:07 PM